Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
104 hedge funds and large institutions have $147M invested in Enzo Biochem, Inc. in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 17 closing their positions.
591% more call options, than puts
Call options by funds: $663K | Put options by funds: $96K
47% more capital invested
Capital invested by funds: $100M → $147M (+$47.2M)
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
35% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 26
5% more funds holding
Funds holding: 99 → 104 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.23M |
| 2 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
+$2.76M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.62M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$2.39M |
| 5 |
Renaissance Technologies
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$4.2M |
| 2 |
LSVM
Lone Star Value Management
Old Greenwich,
Connecticut
|
-$2.62M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$2.54M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$2.04M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.82M |
ENZ Hedge Fund Activity: Q2 2016 in Review
104 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2016, worth a combined $147M — up 47% from $100M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ENZ positions and 17 closed out — a net gain of 6 holders — while 35 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $5.23M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $4.2M.
- 104 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2016, up from 99 in Q1 2016.
- Funds reported $147M of Enzo Biochem, Inc. stock for Q2 2016, up 47% quarter-over-quarter.
- 23 funds opened new Enzo Biochem, Inc. positions in Q2 2016 and 17 closed out, a net change of +6 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $5.23M added.
- The largest Enzo Biochem, Inc. seller in Q2 2016 was Manulife (Manufacturers Life Insurance), an estimated $4.2M sold.
Based on aggregated 13F filings for Q2 2016.